Cardiovascular safety of oral hormone replacement: Interim results from the EURAS-HRT study

被引：0
作者：
Dinger, Juergen [1 ]
Assmann, Anita [1 ]
Kolbeck, Ruediger [1 ]
机构：
[1] ZEG Berlin Ctr Epidemiol & Hlth Res, Berlin, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
617
引用
收藏
页码：S270 / S270
页数：1
相关论文
共 50 条
[41]   A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study [J].
Clarke, SC ;
Kelleher, J ;
Lloyd-Jones, H ;
Slack, M ;
Schofield, PM .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (09) :1056-1062
[42]   Hormone replacement therapy (HRT) and risk of urinary incontinence (UI): Results from the postmenopausal estrogen/progestin interventions (PEPI) trial. [J].
Whiteman, M ;
Flaws, J ;
Bush, T .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) :S140-S140
[43]   Sustained platelet GP IIb/IIIa blockade with oral orbofiban: Interim safety and tolerability results of the SOAR study [J].
Deedwania, PC ;
Ferguson, JJ ;
Kereiakes, DJ ;
Fitzgerald, D ;
Anders, RJ ;
Burns, DM ;
Bryzinski, BS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :94A-94A
[44]   Cardiovascular Safety in Users of Different Combined Oral Contraceptives-Final Results from the INAS-SCORE Study [J].
Bardenheuer, Kristina ;
Heinemann, Klaas ;
Thai Do Minh ;
Franke, Christian .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 :42-42
[45]   Case control study of hormone replacement therapy (HRT) and breast cancer in Japanese women. [J].
Takeuchi, M. ;
Saeki, T. ;
Sano, M. ;
Sonoo, H. ;
Honjo, H. ;
Ochiai, K. ;
Sugano, H. ;
Komiike, Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :544S-544S
[46]   Cross-national study of women's use of hormone replacement therapy (HRT) in Europe [J].
Schneider, HPG .
INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 1997, 42 :365-375
[47]   Cardiovascular safety among users of different combined oral contraceptives - final results from the INAS-SCORE study [J].
Heinemann, K. ;
Dinger, J. ;
Minh, T. D. ;
Franke, C. .
CONTRACEPTION, 2017, 96 (04) :292-293
[48]   Prior use of hormone replacement therapy (HRT) and the effects of raloxifene on the risk of vertebral fracture, cardiovascular, and breast cancer events [J].
Johnell, O ;
Kulkarni, P ;
Sarkar, S ;
Stock, J ;
Wong, M ;
Diez-Perez, A .
OSTEOPOROSIS INTERNATIONAL, 2002, 13 :S69-S69
[49]   Prior use of hormone replacement therapy (HRT) and the effects of raloxifene on the risk of vertebral fracture, cardiovascular, and breast cancer events [J].
Johnell, O ;
Kulkarni, P ;
Stock, J ;
Wong, M ;
Agnusdei, D .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 :S39-S39
[50]   When should data and safety monitoring committees share interim results in cardiovascular trials? [J].
Borer, Jeffrey S. ;
Gordon, David J. ;
Geller, Nancy L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (14) :1710-1712
12345